Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis

European Journal of Clinical Investigation

Volumn 31, Issue 2, 2001, Pages 154-155

  Schettler, V ^a   Monazahian, M ^b   Wieland, E ^a   Ramadori, G ^b   Grunewald, R W ^b   Thomssen, R ^b   Muller G A ^a  

^a Centre of Internal Medicine   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

H.E.L.P. system; Hepatitis C reduction; LDL apheresis; LDL cholesterol reduction

Indexed keywords

APOLIPOPROTEIN B; INTERFERON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; RIBAVIRIN; VIRUS RNA;

APHERESIS; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; EVALUATION; EXTRACORPOREAL CIRCULATION; HEPATITIS C VIRUS; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAFETY; VIRUS LOAD; VIRUS RESISTANCE;

BLOOD COMPONENT REMOVAL; HEPATITIS C; HUMANS; LIPOPROTEINS, LDL; VIRAL LOAD;

EID: 0035092213     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00758.x     Document Type: Article

References (4)

1. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
2. Association of hepatitis C virus in human sera with beta-lipoprotein
3. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
4. The H.E.L.P.-LDL apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The H.E.L.P.-Study Group. Heparin-induced extra-corporeal LDL-precipitation